David W. Meek
- Molecular Biology top 1%
- Oncology top 0.5%
- Cancer Research top 1%
- Cell Biology top 1%
- Biotechnology top 0.5%
- Co-authors
- Diane MilneTed R. HuppDavid P. LaneCarol MidgleyCarl W. AndersonUwe KnippschildWalter EckhartDavid G. Campbell
- Topics
- Cancer-related Molecular Pathways (70 papers)Ubiquitin and proteasome pathways (26 papers)Cancer Research and Treatments (20 papers)
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
David W. Meek
84 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Molecular Biology 5.9k
- Oncology 4.3k
- Cancer Research 1.2k
- Cell Biology 969
- Biotechnology 894
Countries citing papers authored by David W. Meek
This map shows the geographic impact of David W. Meek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Meek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Meek more than expected).
Fields of papers citing papers by David W. Meek
This network shows the impact of papers produced by David W. Meek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Meek. The network helps show where David W. Meek may publish in the future.
Co-authorship network of co-authors of David W. Meek
This figure shows the co-authorship network connecting the top 25 collaborators of David W. Meek. A scholar is included among the top collaborators of David W. Meek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Meek. David W. Meek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 38 | |
| 3 | 73 | |
| 4 | 82 | |
| 5 | 127 | |
| 6 | 99 | |
| 7 | 98 | |
| 8 | 61 | |
| 9 | 57 | |
| 10 | 18 | |
| 11 | 8 | |
| 12 | 71 | |
| 13 | 37 | |
| 14 | 13 | |
| 15 | 347 | |
| 16 | 63 | |
| 17 | 9 | |
| 18 | 198 | |
| 19 | 28 | |
| 20 | 24 |
About David W. Meek
David W. Meek is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 86 papers that have together received 7.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (70 papers), Ubiquitin and proteasome pathways (26 papers) and Cancer Research and Treatments (20 papers). The work is most often cited by research in Oncology (4.3k citations), Biotechnology (894 citations) and Molecular Biology (5.9k citations). David W. Meek has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Diane Milne, Ted R. Hupp, David P. Lane, Carol Midgley, Carl W. Anderson, Uwe Knippschild, Walter Eckhart, David G. Campbell, Lynnette Marcar and Jayne Loughery. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.